Description
Disease Indications
Atopic Dermatitis
Manufacturer
Leo Pharma
Usage
Subcutaneous
Medicine approved by
Food and Drug Administration (FDA)
Pharmaceuticals and Medical Devices Agency (PMDA)
Adbry / Adtralza (tralokinumab-ldrm)
$1,300.00
Adbry (tralokinumab-ldrm) is prescription medicine used to treat adults with moderate-to-severe atopic dermatitis (eczema) who don’t get adequate relief from therapies used on the skin (topical).
Additional information
| Package Prefilled syringes | 4 pre-filled syringe x 150 mg |
|---|
Related products
-
Orladeyo (berotralstat)
Price range: $14,000.00 through $50,000.00 Select options This product has multiple variants. The options may be chosen on the product page -
Repatha (evolocumab)
Price range: $500.00 through $1,200.00 Select options This product has multiple variants. The options may be chosen on the product page -
Verquvo (vericiguat)
Price range: $100.00 through $350.00 Select options This product has multiple variants. The options may be chosen on the product page -
Nexletol (bempedoic acid)
$400.00 Select options This product has multiple variants. The options may be chosen on the product page
Reviews
There are no reviews yet.